Article
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Journal of translational medicine - 18 Dec 2009
Anguille Sébastien, Smits Evelien L J M, Cools Nathalie, Goossens Herman, Berneman Zwi N, Van Tendeloo Vigor F I
Abstract excerpt
BACKGROUND: Optimization of the current dendritic cell (DC) culture protocol in order to promote the therapeutic efficacy of DC-based immunotherapy is warranted. Alternative differentiation of monocyte-derived DCs using granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
